Curis to Present at the JMP Securities Healthcare Conference

June 18, 2014 11:03 AM

16 0

Curis, Inc. /quotes/zigman/83229/delayed/quotes/nls/cris CRIS +0.60% , an oncology-focused company developing novel drug candidates for the treatment of human cancers, today announced that the Company will present at the JMP Securities Healthcare Conference at 3:30 p.m. ET on June 25, 2014, in New York City.

Dr. Ali Fattaey, President and Chief Executive Officer, will provide an overview of Curis' proprietary cancer programs including its dual histone deacetylase (HDAC) and phosphoinositide 3-kinase (PI3K) inhibitor, CUDC-907, and its antagonist of inhibitor of apoptosis (IAP) proteins, CUDC-427. Dr. Fa...

Read more

To category page